Existing backers including GlaxoSmithKline and Roche were joined by Pfizer and Woodford Patient Capital for the Cambridge spinout's series C round.

WeDoctor Group, the Tencent and Fosun-backed online health services company formerly known as Guahao, has received $20m from Shandong Tyan Home.

Richard Osborn is leaving his managing director role at healthcare investment fund RecapHealth Ventures for a similar role at CVC unit Telus Ventures.

Genome editing company Editas, backed by Alphabet and Partners Healthcare, has secured $94.4m, pricing the initial public offering at the bottom of the $16 to $18 range.

The company could secure up to $60.8m in proceeds, having previously raised equity and debt from investors such as Novartis, Sanofi and Elan Science One.

Existing backers including GlaxoSmithKline and Roche were joined by Pfizer and Woodford Patient Capital for the Cambridge spinout's series C round.

Cambridge University intellectual property is set to create a potential treatment for increased blood pressure in pulmonary circulation.

Roche-backed AveXis, the developer of a spinal muscular atrophy treatment, intends to issue 4.25 million shares priced between $19 and $21.

Index Ventures spinout Medicxi Ventures has launched with a $230m first fund backed by GlaxoSmithKline and Johnson & Johnson.

Nomura has partnered Keio University to raise an $84m fund aimed at startups in sectors such as space technology, life sciences and regenerative medicine.